Spis treści:
Spis załączników:
SFA_Exemption_Document_EN_espi.pdf (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
SFA_Exemption_Document_EN_espi.pdf (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 98 | / | 2025 | ||||||||
| Date of issue: | 2025-07-25 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Exemption with regartds to Article 1(5)(g) of the Prospectus Regulation | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD notifies that in accordance with Article 1(5)(g) of the Prospectus Regulation and with respect to the bonus share issue voted on the Annual General Meeting of Shareholders of the Company held on 27 June 2025, Sopharma AD is exempt from the obligation to publish a prospectus. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_Exemption_Document_EN_espi.pdfSFA_Exemption_Document_EN_espi.pdf | |||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2025-07-25 | Ognian Ivanov Donev | Executive Director | |||
Źródło:Komunikaty spółek (ESPI)
